Kwok CS, Tiong D, Pradhan A, Andreou AY, Nolan J, Bertrand OF, Curzen N, Urban P, Myint PK, Zaman AG, Loke YK, Mamas MA (2016) Meta-analysis of the prognostic impact of anemia in patients undergoing percutaneous coronary intervention. Am J Cardiol 118(4):610–620. https://doi.org/10.1016/j.amjcard.2016.05.059
Article
PubMed
Google Scholar
Rathod KS, Jones DA, Rathod VS, Bromage D, Guttmann O, Gallagher SM, Mohiddin S, Rothman MT, Knight C, Jain AK, Kapur A, Mathur A, Timmis AD, Amersey R, Wragg A (2014) Prognostic impact of anaemia on patients with ST-elevation myocardial infarction treated by primary PCI. Coron Artery Dis 25(1):52–59. https://doi.org/10.1097/MCA.0000000000000038
Article
PubMed
Google Scholar
Lee PC, Kini AS, Ahsan C, Fisher E, Sharma SK (2004) Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 44(3):541–546. https://doi.org/10.1016/j.jacc.2004.04.047
Article
PubMed
Google Scholar
Da Silveira AD, Ribeiro RA, Rossini AP et al (2008) Association of anemia with clinical outcomes in stable coronary artery disease. Coron Artery Dis 19(1):21–26. https://doi.org/10.1097/MCA.0b013e3282f27c0a
Article
PubMed
Google Scholar
Sabatine MS, Morrow DA, Giugliano RP, Burton PBJ, Murphy SA, McCabe CH, Gibson CM, Braunwald E (2005) Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 111(16):2042–2049. https://doi.org/10.1161/01.CIR.0000162477.70955.5F
Article
CAS
PubMed
Google Scholar
Wester A, Attar R, Mohammad MA et al (2019) Impact of baseline anemia in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a prespecified analysis from the VALIDATE-SWEDEHEART trial. J Am Heart Assoc 8:e012741
Article
CAS
PubMed
PubMed Central
Google Scholar
Nikolsky E, Aymong ED, Halkin A, Grines CL, Cox DA, Garcia E, Mehran R, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Cohen DA, Negoita M, Lansky AJ, Stone GW (2004) Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the controlled Abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. J Am Coll Cardiol 44(3):547–553. https://doi.org/10.1016/j.jacc.2004.03.080
Article
PubMed
Google Scholar
Mamas MA, Fath-Ordoubadi F, Danzi GB, Spaepen E, Kwok CS, Buchan I, Peek N, de Belder MA, Ludman PF, Paunovic D, Urban P (2015) Prevalence and impact of co-morbidity burden as defined by the Charlson co-morbidity index on 30-day and 1- and 5-year outcomes after coronary stent implantation (from the NOBORI-2 study). Am J Cardiol 116(3):364–371. https://doi.org/10.1016/j.amjcard.2015.04.047
Article
PubMed
Google Scholar
Girasis C, Garg S, Raber L et al (2011) SYNTAX score and clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial. Eur Heart J 32(24):3115–3127. https://doi.org/10.1093/eurheartj/ehr369
Article
PubMed
Google Scholar
Hosseini SK, Ansari MJ, Lotfi T et al (2014) Association between preprocedural hemoglobin level and 1-year outcome of elective percutaneous coronary intervention. J Cardiovasc Med (Hagerstown) 15(4):331–335. https://doi.org/10.2459/JCM.0b013e32835ec938
Article
CAS
Google Scholar
Matsue Y, Matsumura A, Abe M et al (2013) Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients. Heart Vessel 28:19–26
Article
Google Scholar
Mehta SK, Frutkin AD, Lindsey JB, House JA, Spertus JA, Rao SV, Ou FS, Roe MT, Peterson ED, Marso SP, National Cardiovascular Data Registry (2009) Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Interv 2(3):222–229. https://doi.org/10.1161/CIRCINTERVENTIONS.108.846741
Article
PubMed
Google Scholar
Bertrand OF, Larose E, Rodes-Cabau J et al (2010) Incidence, range, and clinical effect of hemoglobin changes within 24 hours after transradial coronary stenting. Am J Cardiol 106(2):155–161. https://doi.org/10.1016/j.amjcard.2010.03.013
Article
PubMed
Google Scholar
Sattur S, Harjai KJ, Narula A, Devarakonda S, Orshaw P, Yaeger K (2009) The influence of anemia after percutaneous coronary intervention on clinical outcomes. Clin Cardiol 32(7):373–379. https://doi.org/10.1002/clc.20542
Article
PubMed
PubMed Central
Google Scholar
Cassese S, Byrne RA, Tada T, Pinieck S, Joner M, Ibrahim T, King LA, Fusaro M, Laugwitz KL, Kastrati A (2014) Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart. 100(2):153–159. https://doi.org/10.1136/heartjnl-2013-304933
Article
PubMed
Google Scholar
Tsai ML, Hsieh MJ, Chen CC, Chang SH, Wang CY, Chen DY, Yang CH, Yeh JK, Ho MY, Hsieh IC (2020) Comparison of 9-month angiographic follow-up and long-term clinical outcomes of biodegradable polymer drug-eluting stents and second-generation durable polymer drug-eluting stents in patients undergoing single coronary artery stenting. Acta Cardiol Sin 36(2):97–104. https://doi.org/10.6515/ACS.202003_36(2).20190729A
Article
PubMed
PubMed Central
Google Scholar
Hytonen JP, Taavitsainen J, Laitinen JTT et al (2018) Local adventitial anti-angiogenic gene therapy reduces growth of vasa-vasorum and in-stent restenosis in WHHL rabbits. J Mol Cell Cardiol 121:145–154. https://doi.org/10.1016/j.yjmcc.2018.07.007
Article
CAS
PubMed
Google Scholar
Brasen JH, Kivela A, Roser K et al (2001) Angiogenesis, vascular endothelial growth factor and platelet-derived growth factor-BB expression, iron deposition, and oxidation-specific epitopes in stented human coronary arteries. Arterioscler Thromb Vasc Biol 21(11):1720–1726. https://doi.org/10.1161/hq1101.098230
Article
CAS
PubMed
Google Scholar
Humar R, Kiefer FN, Berns H, Resink TJ, Battegay EJ (2002) Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling. FASEB J 16(8):771–780. https://doi.org/10.1096/fj.01-0658com
Article
CAS
PubMed
Google Scholar
Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39(2):175–191. https://doi.org/10.3758/BF03193146
Article
PubMed
Google Scholar
Nutritional Anaemias (1968) Report of a WHO scientific group. World Health Organ Tech Rep Ser 405:5–37
Google Scholar
Jaffe AS (2013) Third universal definition of myocardial infarction. Clin Biochem 46(1-2):1–4. https://doi.org/10.1016/j.clinbiochem.2012.10.036
Article
PubMed
Google Scholar
Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation. 123(23):2736–2747. https://doi.org/10.1161/CIRCULATIONAHA.110.009449
Article
PubMed
Google Scholar
Jiang L, Gao Z, Song Y, Xu J, Tang X, Wang H, Liu R, Jiang P, Xu B, Yuan J (2018) Impact of anemia on percutaneous coronary intervention in Chinese patients: a large single center data. J Interv Cardiol 31(6):826–833. https://doi.org/10.1111/joic.12570
Article
PubMed
Google Scholar
Giustino G, Kirtane AJ, Baber U, Généreux P, Witzenbichler B, Neumann FJ, Weisz G, Maehara A, Rinaldi MJ, Metzger C, Henry TD, Cox DA, Duffy PL, Mazzaferri EL, Brodie BR, Stuckey TD, Gurbel PA, Dangas GD, Francese DP, Ozan O, Mehran R, Stone GW (2016) Impact of anemia on platelet reactivity and ischemic and bleeding risk: from the assessment of dual antiplatelet therapy with drug-eluting stents study. Am J Cardiol 117(12):1877–1883. https://doi.org/10.1016/j.amjcard.2016.03.034
Article
CAS
PubMed
Google Scholar
Yang A, Pizzulli L, Luderitz B (2006) Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris. Thromb Res 117(4):371–377. https://doi.org/10.1016/j.thromres.2005.04.004
Article
CAS
PubMed
Google Scholar
Lee MS, David EM, Makkar RR, Wilentz JR (2004) Molecular and cellular basis of restenosis after percutaneous coronary intervention: the intertwining roles of platelets, leukocytes, and the coagulation-fibrinolysis system. J Pathol 203(4):861–870. https://doi.org/10.1002/path.1598
Article
CAS
PubMed
Google Scholar
Geng N, Su G, Wang S, Zou D, Pang W, Sun Y (2019) High red blood cell distribution width is closely associated with in-stent restenosis in patients with unstable angina pectoris. BMC Cardiovasc Disord 19(1):175. https://doi.org/10.1186/s12872-019-1159-3
Article
PubMed
PubMed Central
Google Scholar